Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 11, 2024
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndromeRafael Hernani, Mika Aiko, Ruth Victorio, et al.
Annals of Hematology|July 2, 2022
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patientsJosé Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, et al.
American Journal of Hematology|October 25, 2021
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy GroupJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Frontiers in Immunology|March 24, 2023
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registryPer Ljungman, Gloria Tridello, Jose Luis Piñana, et al.
The Journal of Infectious Diseases|July 13, 2023
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell TransplantationJose Luis Piñana, Gloria Tridello, Aliénor Xhaard, et al.
Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.
Frontiers in Immunology|September 28, 2023
Rationale for combined therapies in severe-to-critical COVID-19 patientsAitor Gonzaga, Etelvina Andreu, Luis M Hernández-Blasco, et al.
Cytotherapy|October 28, 2023
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín-Quirós, et al.
Journal of Fungi (Basel, Switzerland)|December 30, 2020
Polymorphisms within the <i>TNFSF4</i> and <i>MAPKAPK2</i> Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics ConsortiumJose Manuel Sánchez-Maldonado, Ana Moñiz-Díez, Rob Ter Horst, et al.
Experimental Hematology & Oncology|September 1, 2020
Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luis Piñana, Rodrigo Martino, Irene García-García, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 11, 2024
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndromeRafael Hernani, Mika Aiko, Ruth Victorio, et al.
Annals of Hematology|July 2, 2022
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patientsJosé Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, et al.
American Journal of Hematology|October 25, 2021
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy GroupJosé Luis Piñana, Lucia López-Corral, Rodrigo Martino, et al.
Frontiers in Immunology|March 24, 2023
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registryPer Ljungman, Gloria Tridello, Jose Luis Piñana, et al.
The Journal of Infectious Diseases|July 13, 2023
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell TransplantationJose Luis Piñana, Gloria Tridello, Aliénor Xhaard, et al.
Blood Advances|January 13, 2026
Allogeneic HCT as Consolidation in B-cell Lymphomas After Exposure to Bispecific Antibodies: A GETH-TC StudyMarta Peña, Giulia Losi, Víctor Navarro, et al.
Frontiers in Immunology|September 28, 2023
Rationale for combined therapies in severe-to-critical COVID-19 patientsAitor Gonzaga, Etelvina Andreu, Luis M Hernández-Blasco, et al.
Cytotherapy|October 28, 2023
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín-Quirós, et al.
Journal of Fungi (Basel, Switzerland)|December 30, 2020
Polymorphisms within the <i>TNFSF4</i> and <i>MAPKAPK2</i> Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics ConsortiumJose Manuel Sánchez-Maldonado, Ana Moñiz-Díez, Rob Ter Horst, et al.
Experimental Hematology & Oncology|September 1, 2020
Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luis Piñana, Rodrigo Martino, Irene García-García, et al.
Pageof 28